DrugCard is an AI-powered drug information platform designed for healthcare professionals and students seeking quick, reliable access to essential medication details. It provides comprehensive drug data including dosing, side effects, interactions, warnings, and patient counseling tips. The tool aims to streamline decision-making and support safe prescribing by delivering information in a clear, concise format directly in your browser.
DrugCard helps pharmacovigilance teams, contract research organizations (CROs), and pharmaceutical companies manage the vast and growing volume of medical literature. Rather than relying on manual reading of dozens or hundreds of journals (many of which may not be globally indexed), DrugCard continuously monitors both global and local sources including non-indexed local journals across many countries and aggregates all potentially relevant publications into a single unified platform.
Users can set up projects by defining countries, drugs or products to monitor, and the platform scans incoming literature automatically. For each detected publication, DrugCard can generate summaries, highlight keywords, and flag articles that contain safety-relevant information. For non-English articles, the platform supports multiple languages and provides translated abstracts or summaries, making global literature more accessible even when original text is in a local language.
Beyond literature screening, DrugCard integrates modules such as an adverse-event database (for incident case management), regulatory intelligence (tracking regulatory updates across jurisdictions), and compliance features aligned with international safety regulations to ensure data integrity, traceability, and audit readiness.
By replacing manual, error-prone workflows often based on spreadsheets, manual journal scanning, and fragmented data gathering DrugCard gives pharmacovigilance teams a centralized, standardized, and efficient way to track drug safety information, generate reports, and produce audit-ready documentation when needed.
Consolidates global and local medical literature (including non-indexed journals) into a single searchable database.
Translates and summarizes articles from many languages making local-language publications accessible to an international team.
Flags safety-relevant publications and highlights key findings automatically, reducing risk of missed signals.
Maintains audit-ready records, traceable workflows, and compliance with regulatory record-keeping standards.
Saves significant time compared to manual screening letting safety teams focus on analysis and decision-making rather than repetitive literature review.
Because much of the content originates from local or unindexed journals, completeness depends on how many of those sources are covered some relevant literature could still be missed if not in the database.
Integration or onboarding for new local journals (especially from underrepresented regions) may take time the process for adding them may not be instant for every country.
Requires subscription / access smaller organizations or teams with limited budget may find costs significant compared to manual approach.
For very niche or rare languages/journals, translation or OCR accuracy might degrade (especially for scanned or poor-quality PDFs), possibly affecting readability or reliability.
Because heavy automation is involved, final decisions (safety signals, regulatory actions) still depend on expert review so the platform reduces but does not eliminate human judgment or risk.
